1. Home
  2. TRVG vs ACHV Comparison

TRVG vs ACHV Comparison

Compare TRVG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.67

Market Cap

211.2M

Sector

Technology

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$3.42

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
ACHV
Founded
2005
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.2M
172.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
TRVG
ACHV
Price
$2.67
$3.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.09
$15.50
AVG Volume (30 Days)
26.7K
814.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.59
N/A
Revenue Next Year
$8.42
N/A
P/E Ratio
$16.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.95
52 Week High
$5.83
$6.03

Technical Indicators

Market Signals
Indicator
TRVG
ACHV
Relative Strength Index (RSI) 46.03 45.81
Support Level N/A $2.69
Resistance Level $3.22 $3.90
Average True Range (ATR) 0.12 0.20
MACD -0.01 0.09
Stochastic Oscillator 37.84 71.95

Price Performance

Historical Comparison
TRVG
ACHV

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: